MétaCan
Menu
Back to cohort
Record W4405891605 · doi:10.1164/rccm.202410-2096st

Updates on the Treatment of Drug-Susceptible and Drug-Resistant Tuberculosis: An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline

2024· article· en· W4405891605 on OpenAlex

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

fundA Canadian funder is recorded on the work.
no affNo Canadian affiliation: this work is invisible to an affiliation-only frame.
No Canadian affiliation. An affiliation-only frame, the usual design, would never have seen this work. It is one of the works that make the case for inverting the frame.

Bibliographic record

VenueAmerican Journal of Respiratory and Critical Care Medicine · 2024
Typearticle
Languageen
FieldMedicine
TopicTuberculosis Research and Epidemiology
Canadian institutionsnot available
FundersUniversity of Colorado School of Medicine, Anschutz Medical CampusNational Center for HIV/AIDS, Viral Hepatitis, STD, and TB PreventionNational Institute of Allergy and Infectious DiseasesFaculty of Medicine and Health, University of SydneyMax Rady College of Medicine, University of ManitobaUniversity of California, San FranciscoNational Heart, Lung, and Blood InstituteSchool of Medicine and Public Health, University of Wisconsin-MadisonCenters for Disease Control and PreventionNational Institutes of HealthUniversidade do PortoUniversità degli Studi di SassariUniversiteit StellenboschUniversity College LondonInsmedPfizerUniversity of RochesterFaculty of Medicine, McGill UniversityU.S. Department of Health and Human ServicesCOPD FoundationMcGill UniversityMannKind CorporationUniversity of Wisconsin-MadisonJohns Hopkins UniversityUniversity of WashingtonUnited States Agency for International DevelopmentCalifornia Department of Public HealthGenentechNational Jewish HealthInfectious Diseases Society of AmericaAdministração Regional de Saúde do Norte, Ministério da SaúdeAstraZenecaCystic Fibrosis FoundationEli Lilly and CompanyUniversity of PittsburghAmerican Thoracic SocietyTexas Biomedical Research InstitutePatient-Centered Outcomes Research InstituteYale UniversityU.S. Department of Veterans AffairsBill and Melinda Gates FoundationOhio State University
KeywordsMedicineGuidelineDrugTuberculosisClinical PracticeDrug resistanceIntensive care medicineFamily medicinePharmacologyPathologyMicrobiology

Abstract

fetched live from OpenAlex

Abstract Background On the basis of recent clinical trial data for the treatment of drug-susceptible and drug-resistant tuberculosis (TB), the American Thoracic Society, U.S. Centers for Disease Control and Prevention, European Respiratory Society, and Infectious Diseases Society of America have updated clinical practice guidelines for TB treatment in children and adults in settings in which mycobacterial cultures, molecular and phenotypic drug susceptibility tests, and radiographic studies, among other diagnostic tools, are available on a routine basis. Methods A Joint Panel representing multiple interdisciplinary perspectives convened with American Thoracic Society methodologists to review evidence and make recommendations using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) and GRADE-ADOLOPMENT (adoption, adaptation, and, as needed, de novo development of recommendations) methodology. Results New drug-susceptible TB recommendations include the use of a novel 4-month regimen for people with pulmonary TB and a shortened 4-month regimen for children with nonsevere TB. Drug-resistant TB recommendation updates include the use of novel regimens containing bedaquiline, pretomanid, and linezolid with or without moxifloxacin. Conclusions All-oral, shorter treatment regimens for TB are now recommended for use in eligible individuals.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.003
metaresearch head score (Gemma)0.007
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesScience and technology studies
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.849
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0030.007
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.003
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.048
GPT teacher head0.436
Teacher spread0.388 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it